ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

Ethonium

HCID 30869
ノート反応
基本情報概要名称と識別子物性化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
108316-83-2
標準SMILES
CCCCCCCCCCOC(=O)C[N+](C)(C)CC[N+](C)(C)CC(=O)OCCCCCCCCCC.[Cl-].[Cl-]
InChIKey
UPCOSYBELNEQAU-UHFFFAOYSA-L
分子式
C30H62Cl2N2O4
平均分子量
585.7 g/mol
単同位体質量
584.4086639

概要

Russian drug; RN given refers to dichloride

名称と識別子

優先名称
Ethonium
IUPAC
(2-decoxy-2-oxoethyl)-[2-[(2-decoxy-2-oxoethyl)-dimethylazaniumyl]ethyl]-dimethylazanium dichloride

名称と別名

EthoniumEtoniumAethoniumN,N'-Bis(2-(decyloxy)-2-oxoethyl)-N,N,N',N'-tetramethyl-1,2-ethanediaminiumetoniiRefChem:1384191,2-ethylenebis(N-dimethylcarbodecyloxymethyl)ammonium dichloridedichloride ethylene-1,2-bis(N-dimethylcarbodecyloxymethyl)ammonium21954-74-5SCHEMBL28175725DTXSID50910680Ethylenebis((carboxymethyl)dimethylammonium), dichloride, didecyl ester
名称をさらに表示
AKOS024399265N,N-Bis(carboxymethyl)-N,N,N',N'-tetramethylethylenediammonium chloride1,2-Ethanediaminium, N,N'-bis(2-(decyloxy)-2-oxoethyl)-N,N,N',N'-tetramethyl-, dichloride1,2-Ethylenediamine, N,N'-dicarboxymethyl-N,N'-dimethyl-, dimethochloride, didecyl esterAMMONIUM, ETHYLENEBIS((CARBOXYMETHYL)DIMETHYL-, DICHLORIDE, DIDECYL ESTERN,N'-Bis(decyloxycarbonylmethyl)-N,N,N',N'-tetramethylethylenediammonium chloride(2-decoxy-2-oxoethyl)-[2-[(2-decoxy-2-oxoethyl)-dimethylazaniumyl]ethyl]-dimethylazanium;dichloride108316-83-2

データベース識別子

CAS
108316-83-2、21954-74-5
PubChem CID
30869
DTXSID
DTXSID50910680

物性

構造計算による物性

極性表面積
52.6 Ų
水素結合供与体数
0
水素結合受容体数
6
回転可能結合数
27
重原子数
38
形式電荷
0
複雑度
501

化学と産業

薬理情報

MeSH Pharmacological Classification · 6 件

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.

Substances that inhibit or arrest DENTAL CARIES formation. (Boucher's Clinical Dental Terminology, 4th ed)

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性化学と産業関連反応化合物ノート